118 related articles for article (PubMed ID: 26977624)
1. [The efficacy of remaxol addition in the treatment of alcohol withdrawal syndrome].
Vinnikova MA; Utkin SI; Nenasteva AY; Zakharov MV
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(1):40-46. PubMed ID: 26977624
[TBL] [Abstract][Full Text] [Related]
2. [Use of remaxol in the combination therapy of post-withdrawal disorders in alcoholic patients with comorbid liver damage].
Bokhan NA; Abolonin AF; Ankudinova IÉ; Kurgak DI; Mandel' AI
Ter Arkh; 2012; 84(10):51-5. PubMed ID: 23227501
[TBL] [Abstract][Full Text] [Related]
3. [EXPERIENCE IN USE OF HEPATOPROTECTOR REMAXOL FOR TREATING LIVER CIRRHOSIS].
Gridchik IE; Kurdyakov AV; Matveev AI
Eksp Klin Farmakol; 2015; 78(12):11-4. PubMed ID: 27051921
[TBL] [Abstract][Full Text] [Related]
4. [Cytoflavin in the detoxification of alcohol-dependent patients].
Minko AI; Linskiĭ IV; Kuz'minov VN; Samoĭlova ES; Goloshchapov VV; Artemchuk KA
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(6):35-40. PubMed ID: 23887449
[TBL] [Abstract][Full Text] [Related]
5. Clinical physiological study of the therapeutic effects of phenytoin in acute alcohol withdrawal and the asthenic-autonomic syndrome in patients with chronic alcoholism.
Ilyuchina VA; Nikitina LI
Alcohol; 1995; 12(6):511-7. PubMed ID: 8590611
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of pregabalin in the treatment of alcohol withdrawal syndrome: a randomized placebo-controlled trial.
Förg A; Hein J; Volkmar K; Winter M; Richter C; Heinz A; Müller CA
Alcohol Alcohol; 2012; 47(2):149-55. PubMed ID: 22215002
[TBL] [Abstract][Full Text] [Related]
7. [Characteristics of the pharmacological treatment of toxic liver damage in patients with an alcohol abused syndrome and an acute severe ethanol poison].
Shilov VV; Shikalova IA; Vasil'ev SA; Loladze AT; Batotsyrenov BV
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(1):45-8. PubMed ID: 22678675
[TBL] [Abstract][Full Text] [Related]
8. [Comparative effectiveness hepatotropic activity remaxol and Essentiale N in chronic viral hepatitis].
Pavelkina VF; Ampleeva NP
Eksp Klin Farmakol; 2014; 77(12):17-21. PubMed ID: 25739188
[TBL] [Abstract][Full Text] [Related]
9. [PLACE REMAXOL AS A HEPATOPROTECTOR IN INTENSIVE THERAPY OF PERVASIVE PERITONITIS].
Orlov YP; Lukach VN; Govorova NV; Gluschenko AV; Dmitriva OD
Anesteziol Reanimatol; 2015; 60(6):24-9. PubMed ID: 27025129
[TBL] [Abstract][Full Text] [Related]
10. [AGE-SPECIFIC METABOLIC THERAPY FOR ALCOHOL DEPENDENCE IN ELDERLY PATIENTS WITH REGARD TO THEIR AKMEOLOGICAL FEATURES].
Zaplutanov VA; Spikina AA; Belov VG; Parfyonov UA; Ermishin YV
Adv Gerontol; 2015; 28(2):374-80. PubMed ID: 26856103
[TBL] [Abstract][Full Text] [Related]
11. [Effectiveness of the hepatoprotective activity of reamberine, remaxol, and ademethionine and risk assessment in their use in patients with respiratory tuberculosis and drug-induced liver injury].
Sukhanov DS
Ter Arkh; 2012; 84(11):26-9. PubMed ID: 23252243
[TBL] [Abstract][Full Text] [Related]
12. Oxazepam versus clomethiazol in alcohol withdrawal treatment.
de Millas W; Ganzer F; Kuhn S; Haasen C
Eur Addict Res; 2010; 16(4):179-84. PubMed ID: 20606442
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of a combination of flumazenil and gabapentin in the treatment of alcohol dependence: relationship to alcohol withdrawal symptoms.
Anton RF; Myrick H; Baros AM; Latham PK; Randall PK; Wright TM; Stewart SH; Waid R; Malcolm R
J Clin Psychopharmacol; 2009 Aug; 29(4):334-42. PubMed ID: 19593171
[TBL] [Abstract][Full Text] [Related]
14. [Use of infusion solution remaxol in the combination treatment of patients with leptospirosis].
Lebedev VV; Zhuravlev AIu; Zotov SV; Lebedev PV; Pronin MG; Podsadniaia AA; Arbuzova EK; Svistunov NV
Ter Arkh; 2013; 85(11):58-61. PubMed ID: 24432601
[TBL] [Abstract][Full Text] [Related]
15. [Using metabolic cytoprotector Remaxol for urgently increased stability towards acute decompression syndrome].
Starovoĭt AV; Pastushenkov VL; Shitov AIu; Miasnikov AA
Med Tr Prom Ekol; 2010; (9):40-5. PubMed ID: 21089441
[TBL] [Abstract][Full Text] [Related]
16. Intensity of symptoms from alcohol withdrawal in alcohol-dependent patients: comparison between smokers and non-smokers.
Jacques D; Zdanowicz N; Reynaert C; Janne P; Timary P
Psychiatr Danub; 2011 Sep; 23 Suppl 1():S123-5. PubMed ID: 21894118
[TBL] [Abstract][Full Text] [Related]
17. [Effect of hepatoprotector remaxol infusion on liver function in obstructive jaundice model in rats].
Smirnova NG; Chefu SG; Kovalenko AL; Vlasov TD
Eksp Klin Farmakol; 2010 Sep; 73(9):24-7. PubMed ID: 21086649
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacological correction of toxic liver damage in patients with heavy forms of acute ethanol intoxication].
Shikalova IA; Shilov VV; Vasil'ev SA; Batotsyrenov BV; Loladze AT
Eksp Klin Farmakol; 2012; 75(4):30-3. PubMed ID: 22702109
[TBL] [Abstract][Full Text] [Related]
19. Zonisamide versus diazepam in the treatment of alcohol withdrawal syndrome.
Rubio G; López-Muñoz F; Ponce G; Pascual JM; Martínez-Gras I; Ferre F; Jiménez-Arriero MÁ; Alamo C
Pharmacopsychiatry; 2010 Nov; 43(7):257-62. PubMed ID: 20927698
[TBL] [Abstract][Full Text] [Related]
20. Comparison of clinical outcomes in nonintubated patients with severe alcohol withdrawal syndrome treated with continuous-infusion sedatives: dexmedetomidine versus benzodiazepines.
Crispo AL; Daley MJ; Pepin JL; Harford PH; Brown CV
Pharmacotherapy; 2014 Sep; 34(9):910-7. PubMed ID: 24898418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
